Semicolon Open Nav

Dr. Nidal Moukaddam, M.D./Ph.D & Ashutosh Sabharwal

Exploring the tech revolution for mental health

4 minutes read

February 04,2021

We are living through an era of technological revolution. The number of smartphone users worldwide has been exponentially increasing over the last few years, especially in emerging economies such as India. This has opened up a world of opportunities across many commercial industries. However, applications aiming to improve mental health remain largely untapped. Here, technological innovations in smart medical devices and online platforms could improve access to mental health services, as well as identify warning signs and provide interventions. Thus, if we approach these technologies with responsibility, it could help us bring mental healthcare to people who need it most. Although data-driven services also carry concerns with privacy and confidentiality, emerging research indicates that these technologies are a useful supplement to traditional therapeutic practices. We have countless exciting opportunities waiting to be developed, and we have barely scratched the surface.

The first major asset that technology brings is the ability to provide treatment at scale. Traditional mental healthcare services remain out-of-reach for many, but online services and platforms could provide new delivery models that can reach significantly more people. Such platforms can offer similar styles of therapy provided by mental health practitioners while allowing patients to bypass social taboos or discomfort about visiting a therapist or psychiatrist in a physical location. These models can also improve education and validation of mental health goals among the population.

Mental healthcare technologies could potentially open up opportunities to detect the early onset of psychological symptoms. We have been developing increasingly intimate connections with our devices, allowing devices to examine individual activity patterns closely. This gives them the power to detect patterns that we are unaware of ourselves, and commercial industries use this information to sell commodities.

However, they may also detect and predict the onset of mental health issues early in their development, and alert people to take small steps in rectifying irregularities. These interventions can be personalised to the user, which overcomes the limitations of a generalised and un-relatable public education of mental health. Unfortunately, this potential remains mostly undeveloped and clinical research has yet to test any reliably effective techniques.

Researchers in digital phenotyping learn how data from technology users can detect, record, and predict health diagnoses. For example, the symptoms of depression often include changes in appetite, energy, sleep, and activity – a lot of which phones and wearable can directly detect. Our research has shown that we can use apps to track depression and anxiety levels (Curtis, Pai, Cao, Moukaddam, & Sabharwal, 2019) and the worsening of symptoms carries a specific digital “signature”. Devices that detect significant variations in these patterns could conceivably trigger an alert to the user. This is taken further with the field of digital therapeutics, which aims to provide personalised, data-driven therapy to technology users and can include recommendations to change a routine, like exercising or mindfulness. Such apps could also help people become more aware of their mental state and understand how their symptoms relate to mental health.

Of course, the use of technology has its concerns; privacy and confidentiality being the most obvious ones. This is magnified when collected data is shared with other entities. We also don’t have a physiological definition for ‘normal usage of technology’, so features such as comparing one’s patterns to ‘normal’ or ‘average’ groups in aggregate and anonymised forms becomes problematic. Another concern about the use of technology is related to the underlying nature of mental health conditions. For instance, people that are depressed tend to lack motivation or energy to improve their state, so there is no guarantee that they will utilise their technology as prescribed. In other cases, constant alerts and recommendations may even worsen symptoms to the point where a person needs closer treatment. These are just two of several examples that indicate the need for clinical research to examine data-driven therapies with the same rigour that it tests and develops other modes of treatment.

Technology can help us identify and predict the early onset of symptoms and even provide personalised treatment. Digital phenotyping and digital therapeutics are intense areas of research with exciting and frequent developments. Yet even with these possibilities, technology will always have its limits. With what we know today, digital phenotyping and therapeutics are best used to support a formal treatment plan. Here, feedback between the patient and their symptoms can increase the clarity of their diagnosis, their awareness of physical patterns and triggers, and treatment adherence. We have a chance to work with the mental health community, to experiment, to learn, and to use the power of technology to create breakthroughs that the field so desperately needs.  

Co-written By
Dr. Nidal Moukaddam, M.D./Ph.D

Dr. Nidal Moukaddam, M.D./Ph.D., is an Associate Professor at Baylor College of Medicine where she is the Director of Psychiatry Outpatient Clinics at Ben Taub Hospital. She received her MD from the American University of Beirut and did both her PhD and residency at UTMB in clinical sciences. She is board certified in General Psychiatry & Addiction Medicine and specialises in challenging adult populations: she practices emergency psychiatry at Ben Taub Hospital, a level 1 trauma center in Houston, Texas, with a special focus on individuals afflicted with both psychosis and addiction. She is the Continuing Medical Education director for the National Arab-American Medical Association, and is passionate about normalising the conversation around mental wellness and culturally appropriate care. Moukaddam’s research interests focus on how psychiatry can benefit from technological advances for detection, tracking, diagnosis and treatment of mental illness. She is the Harris Health site Investigator for The McNair Initiative for neuroscience Discovery (MIND-2), which uses a combination of biobehavioral sensing and functional imaging to enhance our ability to assess and quantify impulsivity in people with mood disorders and addiction. Moukaddam has supervised many students and residents, leading to numerous awards including Women of Excellence Award at Baylor College of Medicine (2020), the Faculty Mentorship & Teaching award for Baylor Psychiatry Department (2018), being selected for Houstonia magazine- Houston top 100 doctors selection (2017) and Baylor College of Medicine, Department of Psychiatry & Behavioral Sciences’ Outstanding Mentor Award (2017). She is also the creator of a wellness curriculum for Baylor College of Medicine’s Center of Excellence in Health Equity, Training and Research. 

Ashutosh Sabharwal

Ashutosh Sabharwal received his B.Tech. from IIT Delhi, and MS, Ph.D. degrees from the Ohio State University. He is currently the Department Chair and Earnest D. Butcher Chaired Professor of Engineering in the Department of Electrical and Computer Engineering, Rice University, Houston, Texas. He research interests are in two areas. His first area of research is wireless. He is the founder of WARP project (, an open-source project which is now in use at more than 125 research groups worldwide, and have been used by more than 500 research articles. His inventions are part of both wireline and wireless networks. His second area of research is healthcare technologies. He is currently leading several NSF-funded center-scale projects, notably Rice RENEW (open-source massive MIMO) and “See below the skin” for non-invasive bio-imaging. He founded the Rice Scalable Health Labs (, which is developing a new engineering area called “bio-behavioral sensing.” His research has led to four commercial spinoffs (one in wireless and three in healthcare). He is a Fellow of IEEE, and received 2017 IEEE Jack Neubauer Memorial Award, 2018 IEEE Advances in Communications Award, 2019 ACM Test-of-time Award and 2019 ACM MobiCom Community Contribution Award.

Subscribe to Semicolon

Receive updates on everything new at Semicolon. We promise never to spam you!